Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.: STAT6 mutations in mediastinal B-cell lymphoma

Abstract : Primary mediastinal B-cell lymphoma (PMBL) is a separate entity of aggressive B-cell lymphoma, characterized by a constitutive activation of janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, also observed in Hodgkin lymphoma. Although many cancers exhibit constitutive JAK-STAT pathway activation, mutations of STAT genes have not been reported in neoplasms. Here, we show that MedB-1 PMBL-derived and L1236 Hodgkin-derived cell lines and 20 of 55 (36%) PMBL cases harbor heterozygous missense mutations in STAT6 DNA binding domain, whereas no mutation was found in 25 diffuse large B-cell lymphoma samples. In 3 cases, somatic origin was indicated by the absence of the mutations in the nontumoral tissue. The pattern of STAT6 mutations was different from the classical features of somatic hypermutations. The mutant STAT6 proteins showed a decreased DNA binding ability in transfected HEK cells, but no decrease in expression of STAT6 canonical target genes was observed in PMBL cases with a mutated STAT6 gene. Although the oncogenic properties of STAT6 mutant proteins remain to be determined, their recurrent selection in PMBL strongly argues for their involvement in the pathogenesis of this aggressive B-cell lymphoma.
Type de document :
Article dans une revue
Blood, American Society of Hematology, 2009, 114 (6), pp.1236-42. 〈10.1182/blood-2009-03-209759〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00411059
Contributeur : Georges Guellaen <>
Soumis le : mardi 25 août 2009 - 17:07:37
Dernière modification le : mardi 5 décembre 2017 - 17:06:01
Document(s) archivé(s) le : mardi 15 juin 2010 - 19:20:36

Identifiants

Collections

Citation

Olga Ritz, Chrystelle Guiter, Flavia Castellano, Karola Dorsch, Julia Melzner, et al.. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.: STAT6 mutations in mediastinal B-cell lymphoma. Blood, American Society of Hematology, 2009, 114 (6), pp.1236-42. 〈10.1182/blood-2009-03-209759〉. 〈inserm-00411059〉

Partager

Métriques

Consultations de la notice

921

Téléchargements de fichiers

1005